Jochen Buechner
Oslo, Norway
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 84 publications
Long-Term Clinical Outcomes of Tisagenlecleucel in Pediatric and Young Adult Patients With Relapsed/Refractory ALL.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: July 29, 2026
Transdifferentiation of Pediatric Pre-B-ALL Into Histiocytic Sarcoma Harboring BRAF and FLT3 Mutations: Durable Remission With MEK Inhibition, Surgery, and Allogeneic Stem Cell Transplantation.
Journal: Pediatric blood & cancer
Published: May 25, 2026
Sinusoidal obstruction syndrome in children with B-acute lymphoblastic leukemia (B-ALL) treated with inotuzumab ozogamicin: Results from the ITCC-059 trial.
Journal: HemaSphere
Published: May 06, 2026
Tisagenlecleucel for post-transplant relapse in young acute lymphoblastic leukemia patients: European real-world determinants of outcome.
Journal: Leukemia
Published: April 03, 2026
Inotuzumab ozogamicin in paediatric very high risk first B-cell acute lymphoblastic leukaemia relapse (ITCC-059): a multicentre, single-arm, phase 2 trial.
Journal: The Lancet. Haematology
Published: January 27, 2026
Erratum to: "Donor cytomegalovirus serology impacts overall survival in children receiving first unrelated hematopoietic stem cell transplant for acute leukemia: European Society of Bone Marrow Transplantation Pediatric Diseases Working Party Study".
Journal: Haematologica
Published: November 01, 2025
Opportunities and Challenges With CAR T-cell Treatment of Children and Young Adults With B-Cell Acute Lymphoblastic Leukemia: Review and Recommendations From the Westhafen Intercontinental Group.
Journal: Transplantation and cellular therapy
Published: August 04, 2025
Last Updated: 09/26/2026